Overview

A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how many HIV-infected patients continue taking ritonavir/indinavir combination after having taken indinavir three times a day as part of their anti-HIV drug therapy. This study also examines the safety and effectiveness of the ritonavir/indinavir combination.
Phase:
N/A
Details
Lead Sponsor:
Abbott
Treatments:
Indinavir
Ritonavir